Tech

Medtech manufacturer Boston Scientific plans job cuts in Ireland

Published

on

The decision comes just months after the company announced a $75m Galway expansion plan.

Global medical device manufacturer Boston Scientific is planning layoffs at its Irish operations, which employs more than 7,000 workers across facilities in Galway, Cork and Tipperary.

The Massachusetts-headquartered company informed the Department of Enterprise, Tourism and Employment of the upcoming job cuts via a collective redundancy notification on 22 July, RTÉ reported on Wednesday (29 July).

Businesses in Ireland that employ more than 300 people must notify the Government if they plan to cut 30 or more jobs. Globally, the company employs more than 59,000.

Advertisement

The exact extent of the layoffs, however, is unclear. SiliconRepublic.com has requested details from Boston Scientific. The company is still hiring across all three of its locations in Ireland.

The layoffs come just months after the company announced a major $75m expansion of its Galway facilities and a plan to open new, purpose-built laboratories.

Last week, the Boston Scientific approved a global restructuring plan, which it said would lead to “some” headcount reductions. The plan is expected to cost the company between $700m and $800m.

It expects a “substantial portion” of the savings to be reinvested in strategic growth initiatives, according to a regulatory filing on 21 July.

Advertisement

In a statement to RTÉ, a Boston Scientific spokesperson said that the restructuring programme includes “includes enhancing operational and functional capabilities as well as global supply chain network optimisation.

“Ireland has been an important part of Boston Scientific’s global organisation for more than 30 years. We are committed to our long-term future in the country and recognise the significant contributions our employees in Ireland make across our global business.

“In general, we do not break out programme details by business, region or function.”

Net sales at the global medtech grew 7.5pc year-on-year to nearly $5.5bn during the second quarter of 2026.

Advertisement

Don’t miss out on the knowledge you need to succeed. Sign up for the Daily Brief, Silicon Republic’s digest of need-to-know sci-tech news.

Source link

Advertisement

You must be logged in to post a comment Login

Leave a Reply

Cancel reply

Trending

Exit mobile version